- Clinical Characteristics of Diabetes in People with Mitochondrial DNA 3243A>G Mutation in Korea (Diabetes Metab J 2024;48:482-6)
-
Rho EH, Kwak SH
- KMID: 2558049
- Diabetes Metab J.
- 2024 Jul;48(4):818-819.
- doi: 10.4093/dmj.2024.0154
-
- CITED
-
- Close
- SHARE
-
- Close
- Navigating Ultra-Processed Foods with Insight
-
Seo JA
- KMID: 2558038
- Diabetes Metab J.
- 2024 Jul;48(4):713-715.
- doi: 10.4093/dmj.2024.0316
-
- CITED
-
- Close
- SHARE
-
- Close
- Why Are Doctors Not Interested in Type 2 Diabetes Mellitus Remission?
-
Jin HY, Park TS
- KMID: 2558037
- Diabetes Metab J.
- 2024 Jul;48(4):709-712.
- doi: 10.4093/dmj.2024.0312
-
- CITED
-
- Close
- SHARE
-
- Close
- MIDD Patients Should Not Be Confused with MELAS Patients, Even Though Both Carry the m.3243A>G Variant
-
Finsterer J, Mehri S
- KMID: 2558048
- Diabetes Metab J.
- 2024 Jul;48(4):816-817.
- doi: 10.4093/dmj.2024.0065
-
- CITED
-
- Close
- SHARE
-
- Close
- Holistic and Personalized Strategies for Managing in Elderly Type 2 Diabetes Patients
-
Yun JS, Kim K, Ahn YB, Han K, Ko SH
- KMID: 2558035
- Diabetes Metab J.
- 2024 Jul;48(4):531-545.
- doi: 10.4093/dmj.2024.0310
Due to increased life expectancy and lifestyle changes, the prevalence of diabetes among the elderly in Korea is continuously rising, as is the associated public health burden. Diabetes management in... -
- CITED
-
- Close
- SHARE
-
- Close
- Dysfunctional Mitochondria Clearance in Situ: Mitophagy in Obesity and Diabetes-Associated Cardiometabolic Diseases
-
Tang S, Hao D, Ma W, Liu L, Gao J, Yao P, Yu H, Gan L, Cao Y
- KMID: 2558033
- Diabetes Metab J.
- 2024 Jul;48(4):503-517.
- doi: 10.4093/dmj.2023.0213
Several mitochondrial dysfunctions in obesity and diabetes include impaired mitochondrial membrane potential, excessive mitochondrial reactive oxygen species generation, reduced mitochondrial DNA, increased mitochondrial Ca2+ flux, and mitochondrial dynamics disorders. Mitophagy,... -
- CITED
-
- Close
- SHARE
-
- Close
- 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
-
Moon JS, Kang S, Choi JH, Lee KA, Moon JH, Chon S, Kim DJ, Kim HJ, Seo JA, Kim MK, Lim JH, Song YJ, Yang YS, Kim JH, Lee YB, Noh J, Hur KY, Park JS, Rhee SY, Kim HJ, Kim HM, Ko JH, Kim NH, Kim CH, Ahn J, Oh TJ, Kim SK, Kim J, Han E, Jin SM, Bae J, Jeon E, Kim JM, Kang SM, Park JH, Yun JS, Cha BS, Moon MK, Lee BW
- KMID: 2558036
- Diabetes Metab J.
- 2024 Jul;48(4):546-708.
- doi: 10.4093/dmj.2024.0249
-
- CITED
-
- Close
- SHARE
-
- Close
- Temporal Changes in Resting Heart Rate and Risk of Diabetes Mellitus
-
Son MK, Lee K, Park HY
- KMID: 2558042
- Diabetes Metab J.
- 2024 Jul;48(4):752-762.
- doi: 10.4093/dmj.2023.0305
Background: To investigate the association between the time-varying resting heart rate (RHR) and change in RHR (∆RHR) over time and the risk of diabetes mellitus (DM) by sex. Methods: We assessed... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean National Burden of Disease: The Importance of Diabetes Management
-
Kim CN, Jung YS, Kim YE, Ock M, Yoon SJ
- KMID: 2558034
- Diabetes Metab J.
- 2024 Jul;48(4):518-530.
- doi: 10.4093/dmj.2024.0087
Diagnosing the current health status and disease burden in a population is crucial for public health interventions. The ability to compare the burden of different diseases through a single measure,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Prospective 1-Year Follow-Up of Glycemic Status and C-Peptide Levels of COVID-19 Survivors with Dysglycemia in Acute COVID-19 Infection
-
Lui DTW, Lee CH, Wong Y, Fong CHY, Tsoi KH, Woo YC, Tan KCB
- KMID: 2558043
- Diabetes Metab J.
- 2024 Jul;48(4):763-770.
- doi: 10.4093/dmj.2023.0175
Background: We evaluated changes in glycemic status, over 1 year, of coronavirus disease 2019 (COVID-19) survivors with dysglycemia in acute COVID-19. Methods: COVID-19 survivors who had dysglycemia (defined by glycosylated hemoglobin... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial
-
Lee JE, Yu SH, Kim SR, Ahn KJ, Song KH, Lee IK, Shon HS, Kim IJ, Lim S, Kim DM, Chung CH, Lee WY, Lee SH, Kim DJ, Cho SR, Jung CH, Jeon HJ, Lee SH, Park KY, Rhee SY, Kim SG, Park SO, Kim DJ, Kim BJ, Lee SA, Kim YH, Kim KS, Seo JA, Nam-Goong IS, Lee CW, Kim DK, Kim SW, Cho CG, Kim JH, Kim YJ, Yoo JM, Min KW, Lee MK
- KMID: 2558040
- Diabetes Metab J.
- 2024 Jul;48(4):730-739.
- doi: 10.4093/dmj.2023.0077
Background: It is well known that a large number of patients with diabetes also have dyslipidemia, which significantly increases the risk of cardiovascular disease (CVD). This study aimed to evaluate... -
- CITED
-
- Close
- SHARE
-
- Close
- Enhancing Diabetes Care through a Mobile Application: A Randomized Clinical Trial on Integrating Physical and Mental Health among Disadvantaged Individuals
-
Bae JH, Park EH, Lee HK, Yoon KH, Won KC, Kim HM, Kim SG
- KMID: 2558046
- Diabetes Metab J.
- 2024 Jul;48(4):790-801.
- doi: 10.4093/dmj.2023.0298
Background: This study examines integrating physical and mental healthcare for disadvantaged persons with type 2 diabetes mellitus and mild-to-moderate depression in the community, using a mobile application within a public-private-academic... -
- CITED
-
- Close
- SHARE
-
- Close
- Construction of Risk Prediction Model of Type 2 Diabetic Kidney Disease Based on Deep Learning
-
Yun C, Tang F, Gao Z, Wang W, Bai F, Miller JD, Liu H, Lee Y, Lou Q
- KMID: 2558044
- Diabetes Metab J.
- 2024 Jul;48(4):771-779.
- doi: 10.4093/dmj.2023.0033
Background: This study aimed to develop a diabetic kidney disease (DKD) prediction model using long short term memory (LSTM) neural network and evaluate its performance using accuracy, precision, recall, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Diabetes Promotes Myocardial Fibrosis via AMPK/EZH2/PPAR-γ Signaling Pathway
-
Li SS, Pan L, Zhang ZY, Zhou MD, Chen XF, Qian LL, Dai M, Lu J, Yu ZM, Dang S, Wang RX
- KMID: 2558039
- Diabetes Metab J.
- 2024 Jul;48(4):716-729.
- doi: 10.4093/dmj.2023.0031
Background: Diabetes-induced cardiac fibrosis is one of the main mechanisms of diabetic cardiomyopathy. As a common histone methyltransferase, enhancer of zeste homolog 2 (EZH2) has been implicated in fibrosis progression... -
- CITED
-
- Close
- SHARE
-
- Close
- Protein Arginine Methyltransferases: Emerging Targets in Cardiovascular and Metabolic Disease
-
Zhang Y, Wei S, Jin EJ, Jo Y, Oh CM, Bae GU, Kang JS, Ryu D
- KMID: 2558032
- Diabetes Metab J.
- 2024 Jul;48(4):487-502.
- doi: 10.4093/dmj.2023.0362
Cardiovascular diseases (CVDs) and metabolic disorders stand as formidable challenges that significantly impact the clinical outcomes and living quality for afflicted individuals. An intricate comprehension of the underlying mechanisms is... -
- CITED
-
- Close
- SHARE
-
- Close
- Deficiency of ASGR1 Alleviates Diet-Induced Systemic Insulin Resistance via Improved Hepatic Insulin Sensitivity
-
Yu X, Tao J, Wu Y, Chen Y, Li P, Yang F, Tang M, Sammad A, Tao Y, Xu Y, Li YX
- KMID: 2558047
- Diabetes Metab J.
- 2024 Jul;48(4):802-815.
- doi: 10.4093/dmj.2023.0124
Background: Insulin resistance (IR) is the key pathological basis of many metabolic disorders. Lack of asialoglycoprotein receptor 1 (ASGR1) decreased the serum lipid levels and reduced the risk of coronary... -
- CITED
-
- Close
- SHARE
-
- Close
- Associations of Ultra-Processed Food Intake with Body Fat and Skeletal Muscle Mass by Sociodemographic Factors
-
Jung S, Seo J, Kim JY, Park S
- KMID: 2558045
- Diabetes Metab J.
- 2024 Jul;48(4):780-789.
- doi: 10.4093/dmj.2023.0335
Background: The effects of excessive ultra-processed food (UPF) consumption on body composition measures or sociodemographic disparities are understudied in Korea. We aimed to investigate the association of UPF intake with... -
- CITED
-
- Close
- SHARE
-
- Close
- A Composite Blood Biomarker Including AKR1B10 and Cytokeratin 18 for Progressive Types of Nonalcoholic Fatty Liver Disease
-
Choi SJ, Yoon S, Kim KK, Kim D, Lee HE, Kim KG, Shin SK, Park IB, Kim SM, Lee DH
- KMID: 2558041
- Diabetes Metab J.
- 2024 Jul;48(4):740-751.
- doi: 10.4093/dmj.2023.0189
Background: We aimed to evaluate whether composite blood biomarkers including aldo-keto reductase family 1 member B10 (AKR1B10) and cytokeratin 18 (CK-18; a nonalcoholic steatohepatitis [NASH] marker) have clinically applicable performance... -
- CITED
-
- Close
- SHARE
-
- Close
